Paolo A. Ascierto, Director of Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute IRCCS Fondazione “G. Pascale”, Naples, Italy
Leisha A. Emens, Senior Vice President Translational Research, Ankyra Therapeutics, Incorporated, Boston, MA, US; President of Society for Immunotherapy of Cancer (SITC)
Bernard A. Fox, Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Center Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US
Igor Puzanov, Judith and Sanford Lipsey Chair in Clinical Cancer Research; Senior Vice President, Clinical Investigation Chief, Division of Melanoma, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US


The Immunotherapy Bridge will start with a Session jointly organized with SITC on TIL Advancements, CAR-T and TILs.
Hence, we will discuss the state of the art of immunotherapy beyond T cells, novel approches for immune monitoring and the organ specific immune response to share what different cancers teach about the general understanding of malignancies.
The final session will be focused on neoadjuvant therapies across cancers.
Immunotherapy Bridge will end with the Great Debate Sessions, in which the most important issues from clinical practice and research will be shown and exhaustively discussed from two or more different points of view.

La partecipazione è gratuita. Iscrizione obbligatoria fino ad esaurimento posti.

Per informazioni e iscrizioni, inviare una e-mail a

Organizing Secretariat


Scarica il Programma